| Product Code: ETC6569590 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Burkina Faso`s import shipments of exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics in 2024 continued to be dominated by key exporting countries such as India, France, Ghana, Morocco, and China. The high Herfindahl-Hirschman Index (HHI) concentration indicates a competitive market landscape. Despite a slight negative compound annual growth rate (CAGR) from 2020 to 2024, there was a notable growth rate of 10.24% from 2023 to 2024. This suggests a potential uptick in demand for EPI therapeutics and diagnostics in Burkina Faso, highlighting opportunities for market expansion and development in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Overview |
3.1 Burkina Faso Country Macro Economic Indicators |
3.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Industry Life Cycle |
3.4 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Porter's Five Forces |
3.5 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of exocrine pancreatic insufficiency (EPI) in Burkina Faso |
4.2.2 Growing healthcare infrastructure and facilities in the country |
4.2.3 Rising investments in research and development for EPI therapeutics and diagnostics |
4.3 Market Restraints |
4.3.1 Limited access to advanced diagnostic technologies and treatment options in Burkina Faso |
4.3.2 High cost of EPI therapeutics and diagnostics for the average population |
5 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Trends |
6 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Types |
6.1 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Imaging Tests, 2021- 2031F |
6.1.4 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Pancreatic Function Test, 2021- 2031F |
6.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Nutritional Management, 2021- 2031F |
6.2.3 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Pancreatic Enzyme Replacement Therapy, 2021- 2031F |
6.3 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Generic, 2021- 2031F |
6.3.3 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Branded, 2021- 2031F |
6.4 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.4.6 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Research and Academic Institute, 2021- 2031F |
6.4.7 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Import-Export Trade Statistics |
7.1 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Export to Major Countries |
7.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Imports from Major Countries |
8 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Key Performance Indicators |
8.1 Number of healthcare facilities offering EPI diagnosis and treatment services in Burkina Faso |
8.2 Percentage increase in EPI awareness campaigns and educational programs |
8.3 Research and development expenditure on EPI therapeutics and diagnostics in Burkina Faso |
9 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Opportunity Assessment |
9.1 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market - Competitive Landscape |
10.1 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Burkina Faso Exocrine Pancreatic Insufficiency EPI Therapeutics And Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |